StefanNHaringHUHuFB, et al.Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol2013; 1: 152–162.
2.
IacobiniCPuglieseGBlasetti FantauzziC, et al.Metabolically healthy versus metabolically unhealthy obesity. Metabolism2019; 92: 51–60.
3.
HinnouhoGMCzernichowSDugravotA, et al.Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: The Whitehall II cohort study. Eur Heart J2015; 36: 551–559.
4.
KohliPKnowlesJWSarrajuA, et al.Metabolic markers to predict incident diabetes mellitus in statin-treated patients (from the treating to new targets and the stroke prevention by aggressive reduction in cholesterol levels trials). Am J Cardiol2016; 118: 1275–1281.
5.
BarkasFElisafMLiberopoulosE, et al.Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity. J Cardiol2019; 74: 290–295.
6.
BarkasFElisafMLiberopoulosE, et al.Statin therapy with or without ezetimibe and the progression to diabetes. J Clin Lipidol2016; 10: 306–313.
7.
KuwabaraMKuwabaraRHisatomeI, et al.“Metabolically healthy” obesity and hyperuricemia increase risk for hypertension and diabetes: 5-year Japanese cohort study. Obesity (Silver Spring)2017; 25: 1997–2008.
8.
JungCHKangYMJangJE, et al.Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity. Obesity (Silver Spring)2016; 24: 1373–1379.
9.
SungKCLeeMYKimYH, et al.Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver. Atherosclerosis2018; 275: 50–57.
10.
CaleyachettyRThomasGNToulisKA, et al.Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol2017; 70: 1429–1437.
11.
KoolhaasCMDhanaKSchoufourJD, et al.Impact of physical activity on the association of overweight and obesity with cardiovascular disease: The Rotterdam Study. Eur J Prev Cardiol2017; 24: 934–941.
12.
Vallejo-VazAJKondapally SeshasaiSRKurogiK, et al.Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes. Atherosclerosis2015; 241: 409–418.
13.
KouvariMPanagiotakosDBYannakouliaM, et al.Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study. Metabolism2019; 93: 18–24.
